View in EDS HTML Full Text PDF Full Text

Open Label Vancomycin in Primary Sclerosing Cholangitis-Inflammatory Bowel Disease: Improved Colonic Disease Activity and Associations With Changes in Host–Microbiome–Metabolomic Signatures.

Saved in:
Bibliographic Details
Title: Open Label Vancomycin in Primary Sclerosing Cholangitis-Inflammatory Bowel Disease: Improved Colonic Disease Activity and Associations With Changes in Host–Microbiome–Metabolomic Signatures.
Authors: Quraishi, Mohammed Nabil1,2,3,4,5,6 (AUTHOR), Cheesbrough, Jonathan1,5 (AUTHOR), Rimmer, Peter1,5 (AUTHOR), Mullish, Benjamin H7,8,9 (AUTHOR), Sharma, Naveen1,2,3 (AUTHOR), Efstathiou, Elena2 (AUTHOR), Acharjee, Animesh10,11 (AUTHOR), Gkoutus, Georgios10,11 (AUTHOR), Patel, Arzoo4,5 (AUTHOR), Marchesi, Julian R6 (AUTHOR), Camuzeaux, Stephane11 (AUTHOR), Chappell, Katie11 (AUTHOR), Valdivia-Garcia, Maria A12 (AUTHOR), Ferguson, James4,5 (AUTHOR), Brookes, Matthew J13 (AUTHOR), Walmsley, Martine14 (AUTHOR), Rossiter, Amanda E15 (AUTHOR), Schaik, Willem van15 (AUTHOR), McInnes, Ross S15 (AUTHOR), Cooney, Rachel1 (AUTHOR)
Source: Journal of Crohn's & Colitis. Feb2025, Vol. 19 Issue 2, p1-19. 19p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:18739946
DOI:10.1093/ecco-jcc/jjae189